Michael Kühn, Chief of Acute Leukemia Service at University Medical Center Mainz, shared a post on LinkedIn:
“Outstanding talk at ASH2025 by Johanna Rausch from the lab, about how Menin inhibitors sensitize AML cells for CAR-directed immunotherapy.
Johanna’s presentation highlights an exciting therapeutic avenue with real translational potential that we developed together with our outstanding collaborators Evelyn Ullrich, Philipp Wendel, and Robert Zeiser.
We’re incredibly proud of Johanna’s achievement and her excellent representation of the lab on this international stage. Her ASH Abstract Achievement Award is truly well earned.”
More updates from ASH25.